Systemic lupus erythematosus: latest insight into etiopathogenesis Akhil AkhilRohit BansalArchana Bhatnagar Review 24 May 2023 Pages: 1381 - 1393
Current treatment of systemic lupus erythematosus: a clinician's perspective Pawlak-Buś KatarzynaSchmidt WiktorLeszczyński Piotr Review Open access 12 May 2023 Pages: 1395 - 1407
Efficacy of non-surgical interventions for midfoot osteoarthritis: a systematic review Polly Q. X. LimMerridy J. LithgowShannon E. Munteanu Systematic Review Open access 24 April 2023 Pages: 1409 - 1422
Hypermobility prevalence, measurements, and outcomes in childhood, adolescence, and emerging adulthood: a systematic review Liron BlajwajsJoanne WilliamsJohn Sproule Systematic Review Open access 06 May 2023 Pages: 1423 - 1444
Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results? Zehra OzsoyAdem OzdemirOmer Karadag Observational Research 01 April 2023 Pages: 1445 - 1451
Time interval between the onset of connective tissue disease symptoms and first contact with a rheumatologist: results from the German National Database of collaborative arthritis centers Anna KernderKatja ThieleJohanna Callhoff Observational Research Open access 01 June 2023 Pages: 1453 - 1458
Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study Ciara M. O’BrienGeorge D. KitasThe BIOFLARE Consortium Observational Research Open access 25 May 2023 Pages: 1459 - 1465
Severity and determinants of psychosocial comorbidities in granulomatosis with polyangiitis and their impact on quality of life Abhinav ShrivastavaSiddharth JainAman Sharma Observational Research 09 May 2023 Pages: 1467 - 1477
A survey of Canadian adult rheumatologists’ knowledge, comfort level, and barriers in assessing psychosocial needs of young adults with rheumatic diseases Madhavi PrasadMichelle BatthishRoberta Berard Observational Research 10 May 2023 Pages: 1479 - 1484
Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study Ezgi Deniz BatuAybüke GünalpSeza Özen Observational Research 12 March 2023 Pages: 1485 - 1495
Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis Johanna RoemerAriane KleinGerd Horneff Observational Research Open access 11 April 2023 Pages: 1497 - 1505
Performance of cut-offs adjusted with positive control band intensity in line-blot assays for myositis-specific antibodies Sung Hae ChangSe Rim ChoiYun Jong Lee Short Communication 21 February 2023 Pages: 1507 - 1513
Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis Gouri Mani KoduriAnna PodlasekClive Kelly Biomarkers Open access 18 April 2023 Pages: 1515 - 1523
Racial disparities in comorbidities of patients with psoriatic arthritis Y. RossS. JaleelM. Magrey Comorbidities 05 April 2023 Pages: 1525 - 1529
Awareness, perspectives and satisfaction levels among patients with psoriatic arthritis: a multicentric cross-sectional survey Himanshu PathakMohit GoyalVinod Ravindran Patient Opinion 13 May 2023 Pages: 1531 - 1539
Trends in the incidence of musculoskeletal diseases in Kazakhstan in 2011–2020: an information-analytical study Marlen YessirkepovDana BekaryssovaAidynbek Narkabulov Epidemiology of RMDs 12 May 2023 Pages: 1541 - 1545
Panniculitis as a manifestation of metal-associated autoimmune/inflammatory syndrome induced by adjuvants: a case-based review S. G. Radenska-LopovokA. O. KolesnikovaI. D. Musatov Case Based Review 27 June 2021 Pages: 1547 - 1553
Decline in the incidence of rheumatoid arthritis in north-western Greece in 1980–2019 Aliki I. VenetsanopoulouYannis AlamanosAlexandros A. Drosos Correspondence 13 May 2023 Pages: 1555 - 1556
Rheumatoid arthritis and cardiovascular risk: keep it simple and compassionate Mathias AusserwinklerHans Jörg NeumannBernhard Wernly Correspondence 24 April 2023 Pages: 1557 - 1558
Ixekizumab for brodalumab-induced articular involvement in psoriatic arthritis: beyond IL-17A inhibition Tomoyuki MutohMasataka KudoAkira Tsukada Correspondence 18 April 2023 Pages: 1559 - 1561